Skip to main content
Signal8

Mohan Pankaj

SEC insider (Form 3/4/5 filer). CIK 0001664386. Chairman, President and CEO at Sonnet BioTherapeutics Holdings, Inc. (SONN). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 11, 2023. Located in PRINCETON,, NJ.

Companies Mohan Pankaj has filed insider reports for

  • Sonnet BioTherapeutics Holdings, Inc. (SONN): Director, Officer, Chairman, President and CEO
Mohan Pankaj profile photo

Mohan Pankaj

CIK: 0001664386

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sonnet BioTherapeutics Holdings, Inc. logo
SONN

Sonnet BioTherapeutics Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 11, 2023
    Award
    Direct
    7.6K shares-

1-1 of 1